The compound, semaglutide, has a chemical structure that is very similar to ... the GLP1 receptor agonists like Exenatide, Liraglutde, Dulaglutide, Semaglutide and the dual GLP/ GIP Analogue ...

Key drugs in this category include Novo Nordisk’s Ozempic (semaglutide) and Wegovy (semaglutide), and Eli Lilly’s Trulicity (dulaglutide ... Viking Therapeutics ($5.2bn), Structure Therapeutics ...

Most weight loss drugs were meant to be administered as treatment for those with Type 2 Diabetes Mellitus (T2DM), and weight loss was its unintended side-effect. However, their real purpose has been ...

Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...

A model showing how metallic bonds are formed - the first diagram shows the outer electrons in their atoms, and the second diagram shows that the electrons have become delocalised ...

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...

Osteoarthritis (OA) is a common progressive degenerative disease. Gut microbiota (GM) and their metabolites have been closely associated with the onset, progression, and pathology of OA. GM and their ...